Daniel R. Stevens

Efficacy and Safety of Once-Daily LCP-Tacrolimus Versus Twice-Daily Immediate-Release Tacrolimus in Adult Hispanic Stable Kidney Transplant Recipients: Sub-Group Analysis from a Phase 3 Trial

S. Akkina, G. Guerra, S. Bunnapradist, 2021, Annals of transplantation.

Chronopharmacokinetics and Food-Effects of Single-Dose LCP-tacrolimus in Healthy Volunteers.

R. Alloway, J. Momper, E. Cohen, 2020, Therapeutic drug monitoring.

Effect of Concentration/Dose Ratio in De Novo Kidney Transplant Recipients Receiving LCP-Tacrolimus or Immediate-Release Tacrolimus: Post Hoc Analysis of a Phase 3 Clinical Trial

K. Budde, B. Suwelack, S. Bunnapradist, 2020, Annals of transplantation.

Pharmacokinetics of Once‐Daily Extended‐Release Tacrolimus Tablets Versus Twice‐Daily Capsules in De Novo Liver Transplant

D. DuBay, L. Teperman, W. Chapman, 2019, Clinical pharmacology in drug development.

Evaluation of Flexible Tacrolimus Drug Concentration Monitoring Approach in Patients Receiving Extended‐Release Once‐Daily Tacrolimus Tablets

B. Philosophe, N. Leca, P. West-Thielke, 2018, Journal of clinical pharmacology.